Peck R L
Med Econ. 1979 Aug 6;56(16):29-30, 32, 37-8 passim.
In this article, the Washington editor of MEDICAL ECONOMICS reviews the salient actions taken by the Federal Trade Commission (FTC) against medical societies, physician directors of Blue Shield organizations, Health Systems Agencies, and Professional Services Review Organizations. When interviewed, top-ranking FTC staff officers responded to specific questions regarding the concerns of the agency. The FTC regards the practice of medicine as an activity in which competition must be protected. Thus, the restriction of advertising, setting of free schedules, limitation on the number of physicians, and exclusion of other health-care providers or organizations is regarded as anti-competitive and merits intervention by the FTC. The staff members acknowledge that the Congress may enact laws to control health care costs which would permit practices that the FTC would oppose in the absence of such legislation.
在本文中,《医学经济》的华盛顿编辑回顾了联邦贸易委员会(FTC)针对医学协会、蓝盾组织的医师主管、卫生系统机构以及专业服务审查组织采取的显著行动。在接受采访时,联邦贸易委员会的高级工作人员回答了有关该机构所关注问题的具体提问。联邦贸易委员会将医疗行业视为必须保护竞争的活动领域。因此,限制广告宣传、设定免费时间表、限制医生数量以及排斥其他医疗保健提供者或组织的做法被视为反竞争行为,值得联邦贸易委员会进行干预。工作人员承认,国会可能会颁布控制医疗成本的法律,这些法律可能会允许一些在没有此类立法的情况下联邦贸易委员会会反对的做法。